ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 2604

$801K Total Retail Price of All Prescriptions

Rank: 44 out of 2604

448 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 574 512 1 4
FUROSEMIDE 388 372 2 8
OMEPRAZOLE 380 360 3 5
HYDROCODONE-ACETAMINOPHEN 366 276 S3 4 1
LISINOPRIL 358 322 5 3
METOPROLOL TARTRATE 305 279 6 9
SIMVASTATIN 273 260 7 2
WARFARIN SODIUM 225 211 8 13
POTASSIUM CHLORIDE 222 209 9 16
SERTRALINE HCL 196 187 10 23
IPRATROPIUM-ALBUTEROL 194 194 11 136
METFORMIN HCL 190 153 12 7
POLYETHYLENE GLYCOL 3350 181 163 13 42
CITALOPRAM HBR 173 115 14 18
AMLODIPINE BESYLATE 160 149 15 6
LANTUS 148 125 16 40
GABAPENTIN 144 114 17 12
ATORVASTATIN CALCIUM 138 114 18 19
CARBIDOPA-LEVODOPA 125 125 19 97
ATENOLOL 117 105 20 11
CLOPIDOGREL 117 108 20 39
FINASTERIDE 114 86 22 103
SPIRONOLACTONE 111 90 23 78
ALENDRONATE SODIUM 109 95 24 29
LOSARTAN POTASSIUM 106 102 25 20
QUETIAPINE FUMARATE 104 102 26 66
MIRTAZAPINE 98 93 27 52
DONEPEZIL HCL 97 97 28 28
TAMSULOSIN HCL 93 68 29 30
VENLAFAXINE HCL 89 73 30 259
PRAVASTATIN SODIUM 84 79 31 14
PLAVIX 84 79 31 75
ISOSORBIDE MONONITRATE ER 83 83 33 38
FENTANYL 83 64 S2 33 48
RISPERIDONE 76 64 35 65
DIGOXIN 75 75 36 71
NOVOLOG 75 55 36 89
ACETAMINOPHEN-CODEINE 75 70 S3 36 60
CARVEDILOL 74 65 39 26
PAROXETINE HCL 73 44 40 62
ZETIA 72 62 41 94
COLCRYS 71 68 42 232
GEMFIBROZIL 70 53 43 87
ALLOPURINOL 69 69 44 35
LOVASTATIN 69 43 44 24
VENLAFAXINE HCL ER 67 66 46 107
DIOVAN 64 63 47 123
SEROQUEL 61 53 48 149
LEVEMIR 60 32 49 171
CRESTOR 60 54 49 47
METOPROLOL SUCCINATE 58 48 51 17
BACLOFEN 57 23 52 101
OLANZAPINE 55 44 53 115
METOCLOPRAMIDE HCL 54 46 54 181
ZOSTAVAX 53 43 55 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.